Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval
Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...
Endocrinology Advisor3d
SGLT2 Inhibitor Use May Help Prevent Kidney Stones in Patients Without Diabetes
“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...
People7d
FDA Approves Ozempic to Treat Kidney Disease
Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...
education.uiowa.edu12d
Iowa researchers study effects of cholesterol-lowering drugs on kidney function
A University of Iowa research team has found that a class of cholesterol-lowering drugs have no effect on kidney function.
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
McKnight's Long-Term Care News6d
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
Renal & Urology News8d
SGLT2 Inhibitor Use May Help Prevent Kidney Stones in Patients Without Diabetes
Empagliflozin use can reduce the risk of calcium and uric acid kidney stones in patients without ... Disclosure: Trial drugs and laboratory testing were provided by Boehringer Ingelheim.